Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Journal of Gastrointestinal Oncology
|
January 24, 2022
Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report
Douglas Rubinson, Brian M Wolpin, Ilana S Warsofsky, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 4, 2018
Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal Cancer
Howard Safran, Kara-Lynne Leonard, Kimberly Perez, et al.
Pancreas
|
November 17, 2022
A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors
Kimberly Perez, Matthew H Kulke, Nora K Horick, et al.
Endocrine-Related Cancer
|
June 22, 2022
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma
Kimberly Perez, Heather Jacene, Jason L Hornick, et al.
The American Journal of Surgical Pathology
|
May 10, 2024
Transcriptionally Active Human Papillomavirus Infection in a Minority of Esophageal Squamous Cell Carcinomas in North America
Anna H Bauer, Khaled J Alkhateeb, Agoston T Agoston, et al.
Journal of Genetic Counseling
|
February 26, 2022
Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer
Rachel Hodan, Linda Rodgers-Fouche, Sanjeevani Arora, et al.
Annals of the New York Academy of Sciences
|
October 15, 2013
New therapeutic strategies for squamous cell cancer and adenocarcinoma
Bas P L Wijnhoven, Eelke L A Toxopeus, Daniel Vallböhmer, et al.
Nature Communications
|
April 28, 2023
Pancreatic cancer is associated with medication changes prior to clinical diagnosis
Yin Zhang, Qiao-Li Wang, Chen Yuan, et al.
JCO Precision Oncology
|
January 7, 2022
Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs)
Kimberly Perez, Matthew H Kulke, Anu Chittenden, et al.
American Journal of Clinical Oncology
|
May 8, 2013
Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study
Howard Safran, Kevin P Charpentier, Andreas Kaubisch, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Journal of Gastrointestinal Oncology
|
January 24, 2022
Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report
Douglas Rubinson, Brian M Wolpin, Ilana S Warsofsky, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 4, 2018
Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal Cancer
Howard Safran, Kara-Lynne Leonard, Kimberly Perez, et al.
Pancreas
|
November 17, 2022
A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors
Kimberly Perez, Matthew H Kulke, Nora K Horick, et al.
Endocrine-Related Cancer
|
June 22, 2022
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma
Kimberly Perez, Heather Jacene, Jason L Hornick, et al.
The American Journal of Surgical Pathology
|
May 10, 2024
Transcriptionally Active Human Papillomavirus Infection in a Minority of Esophageal Squamous Cell Carcinomas in North America
Anna H Bauer, Khaled J Alkhateeb, Agoston T Agoston, et al.
Journal of Genetic Counseling
|
February 26, 2022
Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer
Rachel Hodan, Linda Rodgers-Fouche, Sanjeevani Arora, et al.
Annals of the New York Academy of Sciences
|
October 15, 2013
New therapeutic strategies for squamous cell cancer and adenocarcinoma
Bas P L Wijnhoven, Eelke L A Toxopeus, Daniel Vallböhmer, et al.
Nature Communications
|
April 28, 2023
Pancreatic cancer is associated with medication changes prior to clinical diagnosis
Yin Zhang, Qiao-Li Wang, Chen Yuan, et al.
JCO Precision Oncology
|
January 7, 2022
Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs)
Kimberly Perez, Matthew H Kulke, Anu Chittenden, et al.
American Journal of Clinical Oncology
|
May 8, 2013
Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study
Howard Safran, Kevin P Charpentier, Andreas Kaubisch, et al.
Page
of 7